Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
3,012.40
3,227.10
3,115.40
2,986.00
2,746.10
2,887.50
2,775.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,012.40
3,227.10
3,115.40
2,986.00
2,746.10
2,887.50
2,775.00
Raw Material Cost
392.80
466.00
414.80
407.50
363.00
423.40
392.60
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
3.30
3.30
3.70
3.00
2.80
7.50
Selling and Distribution Expenses
493.70
487.00
445.10
424.60
396.40
377.60
371.80
Other Expenses
96.16
97.04
97.44
97.47
97.67
99.59
86.84
Total Expenditure (Excl Depreciation)
1,848.10
1,926.70
1,837.60
1,810.50
1,739.10
1,799.70
1,640.30
Operating Profit (PBDIT) excl Other Income
1164.3000000000002
1300.3999999999999
1277.8
1175.5
1007
1087.8
1134.7
Other Income
82.60
91.60
101.30
111.00
143.60
117.60
109.30
Operating Profit (PBDIT)
1,302.80
1,445.10
1,433.10
1,338.20
1,199.00
1,250.50
1,297.20
Interest
0.00
3.30
3.30
3.70
3.00
2.80
7.50
Exceptional Items
6.00
-57.70
-77.00
0.20
-417.20
-66.10
-12.40
Gross Profit (PBDT)
2,619.60
2,761.10
2,700.60
2,578.50
2,383.10
2,464.10
2,382.40
Depreciation
55.90
53.10
54.00
51.70
48.40
45.10
53.20
Profit Before Tax
1,252.90
1,331.00
1,298.80
1,283.00
730.40
1,136.50
1,224.10
Tax
221.50
139.90
215.90
250.10
84.10
223.50
178.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,031.40
1,191.10
1,082.90
1,032.90
646.30
913.00
1,045.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,031.40
1,191.10
1,082.90
1,032.90
646.30
913.00
1,045.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,031.40
1,191.10
1,082.90
1,032.90
646.30
913.00
1,045.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
19,361.90
18,665.80
17,318.80
17,175.40
16,496.30
16,409.60
15,630.90
Earnings per share (EPS)
4.02
4.65
4.2
3.99
2.49
3.5
4.01
Diluted Earnings per share
4.02
4.65
4.2
3.99
2.49
3.5
4.01
Operating Profit Margin (Excl OI)
38.65%
40.3%
41.02%
39.37%
36.67%
37.67%
40.89%
Gross Profit Margin
43.45%
42.89%
43.42%
44.7%
28.36%
40.92%
46.03%
PAT Margin
34.24%
36.91%
34.76%
34.59%
23.54%
31.62%
37.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -6.65% vs 3.59% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -13.41% vs 9.99% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -9.85% vs 1.63% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Vertex Pharmaceuticals, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
3,012.40
11,489.00
-8,476.60
-73.78%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,012.40
11,489.00
-8,476.60
-73.78%
Raw Material Cost
392.80
3,873.00
-3,480.20
-89.86%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
411.00
-411.00
-100.00%
Selling and Distribution Expenses
493.70
1,617.00
-1,123.30
-69.47%
Other Expenses
96.16
182.70
-86.54
-47.37%
Total Expenditure (Excl Depreciation)
1,848.10
7,728.00
-5,879.90
-76.09%
Operating Profit (PBDIT) excl Other Income
1,164.30
3,761.00
-2,596.70
-69.04%
Other Income
82.60
357.00
-274.40
-76.86%
Operating Profit (PBDIT)
1,302.80
4,729.00
-3,426.20
-72.45%
Interest
0.00
411.00
-411.00
-100.00%
Exceptional Items
6.00
-468.00
474.00
101.28%
Gross Profit (PBDT)
2,619.60
7,616.00
-4,996.40
-65.60%
Depreciation
55.90
611.00
-555.10
-90.85%
Profit Before Tax
1,252.90
3,239.00
-1,986.10
-61.32%
Tax
221.50
561.00
-339.50
-60.52%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,031.40
2,677.00
-1,645.60
-61.47%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,031.40
2,677.00
-1,645.60
-61.47%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
1.00
-1.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,031.40
2,678.00
-1,646.60
-61.49%
Equity Capital
0
0
0.00
Face Value
0.01
0.10
0.00
Reserves
19,361.90
20,068.00
-706.10
-3.52%
Earnings per share (EPS)
4.02
1.31
2.71
206.87%
Diluted Earnings per share
4.02
1.31
2.71
206.87%
Operating Profit Margin (Excl OI)
38.65%
32.74%
0.00
5.91%
Gross Profit Margin
43.45%
33.51%
0.00
9.94%
PAT Margin
34.24%
23.30%
0.00
10.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 301.24 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -6.65% vs 3.59% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 9.70% vs 2.19% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 103.14 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -13.41% vs 9.99% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 59.59% vs -41.22% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 122.02 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -9.85% vs 1.63% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 15.61% vs -16.65% in Mar 2025
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.65%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
